Are you Dr. Cutler?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 79 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
44 Binney Streetd1b30
Danafarber Cancer Institute
Boston, MA 02115Phone+1 617-632-5946Fax+1 617-632-5168- Is this information wrong?
Summary
- Dr. Corey Cutler, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts, Vermont, and Florida. He is affiliated with Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Salem Hospital.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1999 - 2002
- McGill University Faculty of MedicineClass of 1996
Certifications & Licensure
- FL State Medical License 2022 - Present
- MA State Medical License 1999 - 2026
- VT State Medical License 2023 - 2024
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) Start of enrollment: 2004 Jan 01
- Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease Start of enrollment: 2004 Jan 01
- Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation Start of enrollment: 2003 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 190 citationsPhase I trial of maintenance sorafenib after allogeneic hematopoietic stem cell transplantation for fms-like tyrosine kinase 3 internal tandem duplication acute myeloi...Yi Bin Chen, Shuli Li, Andrew A. Lane, Christine Connolly, Candice Del Rio
Biology of Blood and Marrow Transplantation. 2014-12-01 - 46 citationsHLA-Identical Sibling Allogeneic Transplants versus Chemotherapy in Acute Myelogenous Leukemia with t(8;21) in First Complete Remission: Collaborative Study between th...Richard F. Schlenk, Marcelo C. Pasquini, Waleska S. Pérez, Mei-Jie Zhang, Jürgen Krauter
Biology of Blood and Marrow Transplantation. 2008-02-01 - 155 citationsEffect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trialStephanie J. Lee, David Zahrieh, Edward Agura, Margaret L. MacMillan, Richard T. Maziarz
Blood. 2004-09-01
Press Mentions
- FDA Approves Treatment for Chronic Graft Versus Host DiseaseSeptember 6th, 2024
- Notice of Compliance Issued Regarding Rezurock(TM) (Belumosudil Tablets)March 21st, 2023
- GVHD Alliance to Honor Steven Pavletic with the Inaugural Lukas D. Wartman GVHD Achievement AwardFebruary 16th, 2023
- Join now to see all
Hospital Affiliations
- Brigham and Women's HospitalBoston, Massachusetts
- Dana-Farber Cancer InstituteBoston, Massachusetts
- Salem HospitalSalem, Massachusetts